Emily Cheng
6Patents
2h-index
15Co-inventors
44Inventor score
Filing activity: Feb 24, 2000 → Aug 12, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6570002B1 | Inhibitor of programmed cell death | Human Necessities | 15 | Expired |
| US8501811B2 | TASPASE1 inhibitors and their uses | Chemistry; Metallurgy | 3 | Active |
| US7964700B2 | Inhibitors of Taspase1 protease activity | Chemistry; Metallurgy | 1 | Active |
| US10610521B2 | Biomarkers for response to rapamycin analogs | Chemistry; Metallurgy | 0 | Active |
| US11098021B2 | Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases | Chemistry; Metallurgy | 0 | Active |
| US10975051B2 | Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.